Search

everythinglearnresearchcommunity

for

Search:↓

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Low-level laser therapy is safe but not significantly better than minoxidil alone for hair growth.

Injections improve hair growth, density, and thickness in women safely.

Injecting platelet-rich plasma into the scalp stimulates hair growth, increases hair density, and treats hair loss effectively with minimal side effects.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

Female pattern hair loss affects crown, increases with age, and has limited treatments.

Substances from dental stem cells might help treat hair loss.

Hair changes can indicate systemic diseases or medication effects.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

The serum increased hair density and was well-tolerated, but didn't affect hair thickness or shedding.

The HairLux device safely and effectively promotes hair growth in people with hair loss.

A supplement with Serenoa repens improved hair loss in a patient.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

A specific signal from hair cells controls the tightening of the surrounding muscle, which is necessary for hair shedding.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

New genes found linked to balding, may help develop future treatments.

Effective hair loss assessment requires a mix of precise measurement methods.

Immune cells affect hair growth and could lead to new hair loss treatments.